Reckitt Benckiser to Stop Selling Suboxone Tablets
Reckitt Benckiser Group Plc (RB/) will cease production of the Suboxone opioid-dependency drug in tablet form, a person familiar with the decision said today.
The person, who declined to be named, said an announcement from the company will be made later today.
To contact the reporter on this story: Matthew Boyle in London at email@example.com
To contact the editor responsible for this story: Sara Marley at firstname.lastname@example.org